How Europe is building a sweeping system to study medication safety in pregnant and lactating women

More than 88 organizations have joined a sweeping new effort in Europe to tackle the research gaps on medication use in pregnant and lactating women.
Source: FRED DUFOUR/AFP/Getty Images

Drug companies, politicians, hospitals, doctors, and patients all agree that there isn’t nearly enough information about whether a given medicine is safe for pregnant and breastfeeding women to use or whether it will work.

A sweeping new effort in Europe aims to change that by bringing all of those groups together to address a public health issue they say demands urgent attention.

The project, dubbed ConcePTION, is a $32 million effort from the Innovative Medicines Initiative, a public-private partnership between the drug industry and the European Commission, the executive branch of the European Union. There are more than 200 researchers and 88 organizations involved in ConcePTION, which is being

You're reading a preview, sign up to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: FDA Advisers Vote Overwhelmingly Against ALS Treatment; Weight-loss Drugs Scrutinized Over Reports Of Suicidal Thoughts
A FDA advisory panel voted overwhelmingly against a polarizing potential treatment for ALS, concluding that supporting data were inadequate.
STAT1 min read
STAT+: The Ozempic Revolution Is Rooted In The Work Of Svetlana Mojsov, Yet She’s Been Edged Out Of The Story
Svetlana Mojsov, on the discovery of GLP-1: “This is not about me getting prizes. It’s about me actually not being erased from the scientific literature.”
STAT1 min read
STAT+: Former FDA Official Lays Out How To Keep Patients Safe From Risky Medical Devices
Former FDA official Madris Kinard built a database to help patients, doctors, and hospitals keep better track of risky medical devices.